Ambeed.cn

首页 / / / / (Rac)-Nutlin-3

(Rac)-Nutlin-3 {[allProObj[0].p_purity_real_show]}

货号:A157368 同义名: Nutlin-3;(Rac)-Rebemadlin

Nutlin 3(Random Configuration) is an MDM2 antagonist which can activate p53 pathway through inhibition of p53-MDM2 interaction.

(Rac)-Nutlin-3 化学结构 CAS号:890090-75-2
(Rac)-Nutlin-3 化学结构
CAS号:890090-75-2
(Rac)-Nutlin-3 3D分子结构
CAS号:890090-75-2
(Rac)-Nutlin-3 化学结构 CAS号:890090-75-2
(Rac)-Nutlin-3 3D分子结构 CAS号:890090-75-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

(Rac)-Nutlin-3 纯度/质量文件 产品仅供科研

货号:A157368 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >

(Rac)-Nutlin-3 生物活性

靶点
  • E3 Ligase

    MDM2, IC50:180 nM

描述 MDM2 binds the p53 tumor suppressor protein with high affinity and negatively modulates its transcriptional activity and stability. Overexpression of MDM2, found in many human tumors, effectively impairs p53 function. Inhibition of MDM2-p53 interaction can stabilize p53 and may offer a novel strategy for cancer therapy[3]. Nutlin 3a is the active enantiomer of nutlin-3, inhibiting the p53/MDM2 interaction, and IC50 was 90 nM in the cell-free test[4]. In vitro, Nutlin-3a replaces p53 from the binding pocket of the MDM2 protein, thereby releasing p53 from a state of inhibition and proteasome degradation, leading to induction of downstream targets, cell cycle arrest and apoptosis. Incubation for 10 μM Nutlin-3a for 7 days resulted in growth inhibition of NIH3T3 cells of over 90%[5]. Nutlin-3a effectively reduced S-phase cells to 0.2-2% and increased G1- and G2/M- phase cells[5]. After 40 h, Nutlin-3a induced apoptosis in about 60% of SJSA-1 and MHM cells, while at 60 h, the apoptotic cells reached 85% and 65%, respectively[5]. In vivo, Nutlin-3a inhibits xenograft growth in a dose-dependent manner, showing large tumor contractions at the highest dose (200 mg/kg). Nutlin-3a is a selective activator of the p53 pathway in vivo and highly effective against SJSA-1 osteosarcoma. Tumors with wild-type p53 and MDM2 amplification responded best to nutlin-3a therapy[5].
作用机制 Nutlin 3 binds MDM2 in the p53-binding pocket [2].

(Rac)-Nutlin-3 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
115 0.5-10 μM Cell Viability Assay 0-6 d inhibits proliferation in a dose-dependent manner 25067787
115 0.5/1/5 μM Function Assay 48 h leads to increased expression of p53 and some p53 target genes: MDM2, and p21 25067787
115 5 μM Growth Inhibition Assay 48 h induces cell cycle arrest  25067787
115 5 μM Function Assay 48 h induces p53-dependent senescence  25067787

(Rac)-Nutlin-3 参考文献

[1]Thompson T, Tovar C, et al. Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J Biol Chem. 2004 Dec 17;279(51):53015-22.

[2]In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

[3]Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science. 2004 Feb 6;303(5659):844-8. doi: 10.1126/science.1092472. Epub 2004 Jan 2. PMID: 14704432.

[4]Crane EK, Kwan SY, Izaguirre DI, Tsang YT, Mullany LK, Zu Z, Richards JS, Gershenson DM, Wong KK. Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas. PLoS One. 2015 Aug 6;10(8):e0135101. doi: 10.1371/journal.pone.0135101. PMID: 26248031; PMCID: PMC4527847.

[5]Tovar C, Rosinski J, Filipovic Z, Higgins B, Kolinsky K, Hilton H, Zhao X, Vu BT, Qing W, Packman K, Myklebost O, Heimbrook DC, Vassilev LT. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy. Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1888-93. doi: 10.1073/pnas.0507493103. Epub 2006 Jan 27. PMID: 16443686; PMCID: PMC1413632.

(Rac)-Nutlin-3 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.72mL

0.34mL

0.17mL

8.60mL

1.72mL

0.86mL

17.20mL

3.44mL

1.72mL

(Rac)-Nutlin-3 技术信息

CAS号890090-75-2
分子式C30H30Cl2N4O4
分子量 581.49
别名 Nutlin-3;(Rac)-Rebemadlin
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,Room Temperature

溶解度
动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。